SFOP0008817: Countering Wildlife Trafficking in Central Africa
Closed
This grant is closed. A newer notice from the same program is open now: Balanced Prosecution of Transnational Organized Crime Cases (OFOP0003790). Status: Closes November 9, 2026 (2 days left). It is in our archive of Bureau of International Narcotics-Law Enforcement notices from 2022.
Bureau of International Narcotics-Law Enforcement offered grants of up to $1.5 million (at least $1.3 million) to the applicants described in the notice. It expected to make one award. Applications closed on June 1, 2022.
From the official notice on Grants.gov, last changed April 1, 2022. Checked November 7, 2026.
- Award ceiling$1.5 million
- Award floor$1.3 million
- Expected awards1
- Cost sharingNot required
- Funding typeGrant
Key dates
| Posted | April 1, 2022 |
|---|---|
| Deadline | June 1, 2022 |
Who can apply
This opportunity was open to the applicants described in the notice.
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
• U.S.-based non-profit/non-governmental organizations (NGOs); • U.S.-based educational institutions subject to section 501(c)(3) of the U.S. tax code; • Foreign-based non-profits/non-governmental organizations (NGOs); • Foreign-based educational institutions
Is this a realistic fit?
- Past Trans-National Crime awards averaged $1.3 million; this notice allows up to $1.5 million per award.
- Most of the program's money (62% over five years) went to nonprofits.
- No cost sharing or match is required.
What the grant funds
Strengthen criminal justice institutions in Central Africa to undertake successful enforcement, investigative, and prosecutorial functions for wildlife crimes, as well as credible measures that prevent wildlife crime.
Who has won Trans-National Crime grants before
From fiscal 2021 to 2025, Trans-National Crime (19.705) awarded $352 million across 264 grant awards, an average of $1.3 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| National Center for State Courts | Virginia | 13 | $91.8 million |
| Wildlife Conservation Society | New York | 22 | $37.1 million |
| Traffic International | 16 | $19.0 million | |
| World Wildlife Fund, Inc. | District of Columbia | 6 | $13.6 million |
| The Global Initiative Against Transnational Organized Crime | 3 | $10.0 million |
Applying now
This notice no longer takes applications. Apply under the newer notice, OFOP0003790, which is open now.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is SFOP0008817 still open?
No. It closed on June 1, 2022. A newer notice is open: OFOP0003790, closes November 9, 2026 (2 days left).
Who can apply for Countering Wildlife Trafficking in Central Africa?
Bureau of International Narcotics-Law Enforcement accepted applications from the applicants described in the notice. The notice adds further conditions, so read its eligibility section.
What is the deadline for Countering Wildlife Trafficking in Central Africa?
Closed June 1, 2022. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $1.5 million each.
Who has won Trans-National Crime grants before?
The largest recipients over five fiscal years were National Center for State Courts, Wildlife Conservation Society, Traffic International. The program made 264 awards worth $352 million in that time.
Similar open grants
- Fiscal Year (FY) 2026 Funding Opportunity for Indian Tribes and Intertribal Consortia for Nonpoint Source Management Grants Under Clean Water Act Section 319
- Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)
- Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
- Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)
- DARRP Restoration Implementation Grants (2026)
- Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)